Загрузка...
A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase
BACKGROUND: Vitamin K antagonists (VKAs), such as warfarin, have remained the cornerstone of oral anticoagulation therapy in the prevention and treatment of thromboembolism for over half a century. They function by impairing the biosynthesis of vitamin K-dependent (VKD) clotting factors through the...
Сохранить в:
| Опубликовано в: : | J Thromb Haemost |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7925372/ https://ncbi.nlm.nih.gov/pubmed/33314621 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15209 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|